Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease

Cited by (259)

Items 201–259 of 259

1. Reelin protects against amyloid β toxicity in vivo
   Lane-Donovan, Courtney, Philips, Gary T., Wasser, Catherine R., Durakoglugil, Murat S., Masiulis, Irene, Upadhaya, Ajeet, Pohlkamp, Theresa, Coskun, Cagil, Kotti, Tiina, Steller, Laura et al. · 2015 · Science Signaling
2. Lesions without symptoms: understanding resilience to Alzheimer disease neuropathological changes
   Gómez-Isla, Teresa, Frosch, Matthew P. · 2022 · Nature Reviews Neurology
3. Analysis of the Putative Role of CR1 in Alzheimer’s Disease: Genetic Association, Expression and Function
   Fonseca, Maria I., Chu, Shuhui, Pierce, Aimee L., Brubaker, William D., Hauhart, Richard E., Mastroeni, Diego, Clarke, Elizabeth V., Rogers, Joseph, Atkinson, John P., Tenner, Andrea J. · 2016 · PLOS ONE
4. An intronic VNTR affects splicing of ABCA7 and increases risk of Alzheimer’s disease
   On Behalf of the BELNEU Consortium, De Roeck, Arne, Duchateau, Lena, Van Dongen, Jasper, Cacace, Rita, Bjerke, Maria, Van den Bossche, Tobi, Cras, Patrick, Vandenberghe, Rik, De Deyn, Peter P. et al. · 2018 · Acta Neuropathologica
5. Genome-wide association reveals genetic effects on human Aβ 42 and τ protein levels in cerebrospinal fluids: a case control study
   Han, Mi-Ryung, Schellenberg, Gerard D, Wang, Li-San, the Alzheimer's Disease Neuroimaging Initiative · 2010 · BMC Neurology
6. Role of amyloid beta in lipid homeostasis
   Grösgen, Sven, Grimm, Marcus O.W., Frieß, Petra, Hartmann, Tobias · 2010 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
7. Efficacy and Safety of Probiotics for the Treatment of Alzheimer's Disease, Mild Cognitive Impairment, and Parkinson's Disease: A Systematic Review and Meta-Analysis
   Xiang, Shuai, Ji, Jin-Long, Li, Sha, Cao, Xi-Peng, Xu, Wei, Tan, Lan, Tan, Chen-Chen · 2022 · Frontiers in Aging Neuroscience
8. Microglia communication: parallels between aging and Alzheimer's disease
   Udeochu, Joe C., Shea, Jeremy M., Villeda, Saul A. · 2016 · Clinical and Experimental Neuroimmunology
9. Altered cell and RNA isoform diversity in aging Down syndrome brains
   Palmer, Carter R., Liu, Christine S., Romanow, William J., Lee, Ming-Hsiang, Chun, Jerold · 2021 · Proceedings of the National Academy of Sciences
10. Shifting paradigms: The central role of microglia in Alzheimer’s disease
    Schwabe, Tina, Srinivasan, Karpagam, Rhinn, Herve · 2020 · Neurobiology of Disease
11. BIN1 recovers tauopathy-induced long-term memory deficits in mice and interacts with Tau through Thr348 phosphorylation
    Sartori, Maxime, Mendes, Tiago, Desai, Shruti, Lasorsa, Alessia, Herledan, Adrien, Malmanche, Nicolas, Mäkinen, Petra, Marttinen, Mikael, Malki, Idir, Chapuis, Julien et al. · 2019 · Acta Neuropathologica
12. Whole-genome sequencing suggests a chemokine gene cluster that modifies age at onset in familial Alzheimer's disease
    Lalli, M A, Bettcher, B M, Arcila, M L, Garcia, G, Guzman, C, Madrigal, L, Ramirez, L, Acosta-Uribe, J, Baena, A, Wojta, K J et al. · 2015 · Molecular Psychiatry
13. Enhancer variants associated with Alzheimer’s disease affect gene expression via chromatin looping
    Kikuchi, Masataka, Hara, Norikazu, Hasegawa, Mai, Miyashita, Akinori, Kuwano, Ryozo, Ikeuchi, Takeshi, Nakaya, Akihiro · 2019 · BMC Medical Genomics
14. PICALM Rescues Endocytic Defects Caused by the Alzheimer’s Disease Risk Factor APOE4
    Narayan, Priyanka, Sienski, Grzegorz, Bonner, Julia M., Lin, Yuan-Ta, Seo, Jinsoo, Baru, Valeriya, Haque, Aftabul, Milo, Blerta, Akay, Leyla A., Graziosi, Agnese et al. · 2020 · Cell Reports
15. A potential endophenotype for Alzheimer's disease: cerebrospinal fluid clusterin
    Deming, Yuetiva, Xia, Jian, Cai, Yefei, Lord, Jenny, Holmans, Peter, Bertelsen, Sarah, Holtzman, David, Morris, John C., Bales, Kelly, Pickering, Eve H. et al. · 2016 · Neurobiology of Aging
16. Deleterious ABCA7 mutations and transcript rescue mechanisms in early onset Alzheimer’s disease
    On behalf of the European Early-Onset Dementia (EU EOD) consortium, De Roeck, Arne, Van den Bossche, Tobi, van der Zee, Julie, Verheijen, Jan, De Coster, Wouter, Van Dongen, Jasper, Dillen, Lubina, Baradaran-Heravi, Yalda, Heeman, Bavo et al. · 2017 · Acta Neuropathologica
17. Aβ immunotherapy for Alzheimer’s disease: effects on apoE and cerebral vasculopathy
    Sakai, Kenji, Boche, Delphine, Carare, Roxana, Johnston, David, Holmes, Clive, Love, Seth, Nicoll, James A. R. · 2014 · Acta Neuropathologica
18. Relation of genomic variants for Alzheimer disease dementia to common neuropathologies
    Farfel, Jose M., Yu, Lei, Buchman, Aron S., Schneider, Julie A., De Jager, Philip L., Bennett, David A. · 2016 · Neurology
19. Associations of Alzheimer’s disease risk variants with gene expression, amyloidosis, tauopathy, and neurodegeneration
    Alzheimer’s Disease Neuroimaging Initiative, Tan, Meng-Shan, Yang, Yu-Xiang, Xu, Wei, Wang, Hui-Fu, Tan, Lin, Zuo, Chuan-Tao, Dong, Qiang, Tan, Lan, Suckling, John et al. · 2021 · Alzheimer's Research & Therapy
20. Genetic loci associated with Alzheimer's disease and cerebrospinal fluid biomarkers in a Finnish case–control cohort
    Elias-Sonnenschein, Lyzel S., Helisalmi, Seppo, Natunen, Teemu, Hall, Anette, Paajanen, Teemu, Herukka, Sanna-Kaisa, Laitinen, Marjo, Remes, Anne M., Koivisto, Anne M., Mattila, Kari M. et al. · 2013 · PLoS ONE
21. Dysregulated Wnt Signalling in the Alzheimer’s Brain
    Aghaizu, Nozie D., Jin, Hanqing, Whiting, Paul J. · 2020 · Brain Sciences
22. Immune response and endocytosis pathways are associated with the resilience against Alzheimer’s disease
    Tesi, Niccolò, van der Lee, Sven J., Hulsman, Marc, Jansen, Iris E., Stringa, Najada, van Schoor, Natasja M., Scheltens, Philip, van der Flier, Wiesje M., Huisman, Martijn, Reinders, Marcel J. T. et al. · 2020 · Translational Psychiatry
23. Centenarian controls increase variant effect sizes by an average twofold in an extreme case–extreme control analysis of Alzheimer’s disease
    Tesi, Niccolò, van der Lee, Sven J., Hulsman, Marc, Jansen, Iris E., Stringa, Najada, van Schoor, Natasja, Meijers-Heijboer, Hanne, Huisman, Martijn, Scheltens, Philip, Reinders, Marcel J. T. et al. · 2019 · European Journal of Human Genetics
24. Combined Effects of Alzheimer Risk Variants in the <i>CLU</i> and <i>ApoE</i> Genes on Ventricular Expansion Patterns in the Elderly
    Roussotte, Florence F., Gutman, Boris A., Madsen, Sarah K., Colby, John B., Thompson, Paul M., for the Alzheimer's Disease Neuroimaging Initiative · 2014 · The Journal of Neuroscience
25. Brain high-throughput multi-omics data reveal molecular heterogeneity in Alzheimer’s disease
    Eteleeb, Abdallah M., Novotny, Brenna C., Tarraga, Carolina Soriano, Sohn, Christopher, Dhungel, Eliza, Brase, Logan, Nallapu, Aasritha, Buss, Jared, Farias, Fabiana, Bergmann, Kristy et al. · 2024 · PLOS Biology
26. Modulation of Amyloid-β1–40 Transport by ApoA1 and ApoJ Across an in vitro Model of the Blood-Brain Barrier
    Merino-Zamorano, Cristina, Fernández-de Retana, Sofía, Montañola, Alex, Batlle, Aina, Saint-Pol, Julien, Mysiorek, Caroline, Gosselet, Fabien, Montaner, Joan, Hernández-Guillamon, Mar · 2016 · Journal of Alzheimer's Disease
27. Clusterin Associates Specifically with <scp>A</scp>β40 in <scp>A</scp>lzheimer's Disease Brain Tissue
    Howlett, David R., Hortobágyi, Tibor, Francis, Paul T. · 2013 · Brain Pathology
28. Behavioral and transcriptomic analysis of Trem2-null mice: not all knockout mice are created equal
    Kang, Silvia S, Kurti, Aishe, Baker, Kelsey E, Liu, Chia-Chen, Colonna, Marco, Ulrich, Jason D, Holtzman, David M, Bu, Guojun, Fryer, John D · 2018 · Human Molecular Genetics
29. Parental family history of dementia in relation to subclinical brain disease and dementia risk
    Wolters, Frank J., van der Lee, Sven J., Koudstaal, Peter J., van Duijn, Cornelia M., Hofman, Albert, Ikram, M. Kamran, Vernooij, Meike W., Ikram, M. Arfan · 2017 · Neurology
30. A New Hypothesis for Alzheimer’s Disease: The Lipid Invasion Model
    Rudge, Jonathan D’Arcy · 2022 · Journal of Alzheimer's Disease Reports
31. Structural Basis of Tau Interaction With BIN1 and Regulation by Tau Phosphorylation
    Lasorsa, Alessia, Malki, Idir, Cantrelle, François-Xavier, Merzougui, Hamida, Boll, Emmanuelle, Lambert, Jean-Charles, Landrieu, Isabelle · 2018 · Frontiers in Molecular Neuroscience
32. Role of Family History for Alzheimer Biomarker Abnormalities in the Adult Children Study
    Xiong, Chengjie · 2011 · Archives of Neurology
33. Imaging-wide association study: integrating imaging endophenotypes in GWAS
    Xu, Zhiyuan, Wu, Chong, Pan, Wei · 2017 · NeuroImage
34. A Common Variant of IL-6R is Associated with Elevated IL-6 Pathway Activity in Alzheimer’s Disease Brains
    Haddick, Patrick C.G., Alzheimer’s Disease Genetic Consortium (ADGC), Alzheimer’s Disease Neuroimaging Initiative (ADNI), Larson, Jessica L., Rathore, Nisha, Bhangale, Tushar R., Phung, Qui T., Srinivasan, Karpagam, Hansen, David V., Lill, Jennie R., Pericak-Vance, Margaret A. et al. · 2017 · Journal of Alzheimer's Disease
35. Predicting white matter integrity from multiple common genetic variants
    Kohannim, Omid, Jahanshad, Neda, Braskie, Meredith N, Stein, Jason L, Chiang, Ming-Chang, Reese, April H, Hibar, Derrek P, Toga, Arthur W, McMahon, Katie L, de Zubicaray, Greig I et al. · 2012 · Neuropsychopharmacology
36. Adaptors for disorders of the brain? The cancer signaling proteins NEDD9, CASS4, and PTK2B in Alzheimer’s disease
    Beck, Tim N., Nicolas, Emmanuelle, Kopp, Meghan C., Golemis, Erica A. · 2014 · Oncoscience
37. C1q is increased in cerebrospinal fluid‐derived extracellular vesicles in Alzheimer's disease: A multi‐cohort proteomics and immuno‐assay validation study
    Chatterjee, Madhurima, Özdemir, Selcuk, Kunadt, Marcel, Koel‐Simmelink, Marleen, Boiten, Walter, Piepkorn, Lars, Pham, Thang V., Chiasserini, Davide, Piersma, Sander R., Knol, Jaco C. et al. · 2023 · Alzheimer's &amp; Dementia
38. Pleiotropic Roles of P2X7 in the Central Nervous System
    Kanellopoulos, Jean M., Delarasse, Cécile · 2019 · Frontiers in Cellular Neuroscience
39. SUCLG2 identified as both a determinator of CSF Aβ1–42 levels and an attenuator of cognitive decline in Alzheimer's disease
    Ramirez, Alfredo, van der Flier, Wiesje M., Herold, Christine, Ramonet, David, Heilmann, Stefanie, Lewczuk, Piotr, Popp, Julius, Lacour, André, Drichel, Dmitriy, Louwersheimer, Eva et al. · 2014 · Human Molecular Genetics
40. Deficiency of terminal complement pathway inhibitor promotes neuronal tau pathology and degeneration in mice
    Britschgi, Markus, Takeda-Uchimura, Yoshiko, Rockenstein, Edward, Johns, Hudson, Masliah, Eliezer, Wyss-Coray, Tony · 2012 · Journal of Neuroinflammation
41. Genetic risk factors for Alzheimer disease: emerging roles of microglia in disease pathomechanisms
    Takatori, Sho, Wang, Wenbo, Iguchi, Akihiro, Tomita, Taisuke · 2019 · Advances in Experimental Medicine and Biology
42. Variants in <i>PPP3R1</i> and <i>MAPT</i> are associated with more rapid functional decline in Alzheimer's disease: The Cache County Dementia Progression Study
    Peterson, David, Munger, Caitlin, Crowley, Jared, Corcoran, Chris, Cruchaga, Carlos, Goate, Alison M., Norton, Maria C., Green, Robert C., Munger, Ronald G., Breitner, John C.S. et al. · 2014 · Alzheimer's &amp; Dementia
43. Genetic Variants of Lipoprotein Lipase and Regulatory Factors Associated with Alzheimer’s Disease Risk
    D. Bruce, Kimberley, Tang, Maoping, Reigan, Philip, H. Eckel, Robert · 2020 · International Journal of Molecular Sciences
44. Lower DNA methylation levels in CpG island shores of CR1, CLU, and PICALM in the blood of Japanese Alzheimer’s disease patients
    Mitsumori, Risa, Sakaguchi, Kazuya, Shigemizu, Daichi, Mori, Taiki, Akiyama, Shintaro, Ozaki, Kouichi, Niida, Shumpei, Shimoda, Nobuyoshi · 2020 · PLOS ONE
45. Progress and challenges in the diagnosis of dementia: a critical review
    Paraskevaidi, Maria, Martin-Hirsch, Pierre L., Martin, Francis L. · 2018 · ACS Chemical Neuroscience
46. The Effects of Two Polymorphisms on p21cip1 Function and Their Association with Alzheimer’s Disease in a Population of European Descent
    Yates, Sharon C., Zafar, Amen, Rabai, Erzsebet M., Foxall, James B., Nagy, Sheila, Morrison, Karen E., Clarke, Carl, Esiri, Margaret M., Christie, Sharon, Smith, A. David et al. · 2015 · PLOS ONE
47. Proapoptotic role of nuclear clusterin in brain
    Kim, Nayoung, Choi, Wan Sung · 2011 · Anatomy &amp; Cell Biology
48. Translating Alzheimer’s disease-associated polymorphisms into functional candidates: a survey of IGAP genes and SNPs
    Katsumata, Yuriko, Nelson, Peter T., Estus, Steven, Fardo, David W. · 2019 · Neurobiology of Aging
49. Evidence for three loci modifying age‐at‐onset of Alzheimer's disease in early‐onset <i>PSEN2</i> families
    Marchani, Elizabeth E., Bird, Thomas D., Steinbart, Ellen J., Rosenthal, Elisabeth, Yu, Chang‐En, Schellenberg, Gerard D., Wijsman, Ellen M. · 2010 · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
50. A genome-wide search for pleiotropy in more than 100,000 harmonized longitudinal cognitive domain scores
    Kang, Moonil, Ang, Ting Fang Alvin, Devine, Sherral A., Sherva, Richard, Mukherjee, Shubhabrata, Trittschuh, Emily H., Gibbons, Laura E., Scollard, Phoebe, Lee, Michael, Choi, Seo-Eun et al. · 2023 · Molecular Neurodegeneration
51. Genes, pathways and risk prediction in Alzheimer’s disease
    Hardy, John, Escott-Price, Valentina · 2019 · Human Molecular Genetics
52. Validation of a priori candidate Alzheimer’s disease SNPs with brain amyloid-beta deposition
    Vacher, Michael, Porter, Tenielle, Villemagne, Victor L., Milicic, Lidija, Peretti, Madeline, Fowler, Christopher, Martins, Ralph, Rainey-Smith, Stephanie, Ames, David, Masters, Colin L. et al. · 2019 · Scientific Reports
53. High-density lipoprotein-related cholesterol metabolism in Alzheimer's disease
    Pedrini, Steve, Chatterjee, Pratishtha, Hone, Eugene, Martins, Ralph N. · 2021 · Journal of Neurochemistry
54. Do Microglia default on network maintenance in Alzheimer's disease?
    Southam, Katherine A., Vincent, Adele J., Small, David H. · 2016 · Journal of Alzheimer s Disease
55. Integrative single-nucleus multi-omics analysis prioritizes candidate cis and trans regulatory networks and their target genes in Alzheimer’s disease brains
    Gamache, Julia, Gingerich, Daniel, Shwab, E. Keats, Barrera, Julio, Garrett, Melanie E., Hume, Cordelia, Crawford, Gregory E., Ashley-Koch, Allison E., Chiba-Falek, Ornit · 2023 · Cell &amp; Bioscience
56. Deletion of Crry, the murine ortholog of the sporadic Alzheimer's disease risk gene CR1, impacts tau phosphorylation and brain CFH
    Killick, R., Hughes, T.R., Morgan, B.P., Lovestone, S. · 2013 · Neuroscience Letters
57. CRP gene variation affects early development of Alzheimer's disease-related plaques
    Kok, Eloise, Alanne-Kinnunen, Mervi, Isotalo, Karita, Luoto, Teemu, Haikonen, Satu, Goebeler, Sirkka, Perola, Markus, Hurme, Mikko A, Haapasalo, Hannu, Karhunen, Pekka J · 2011 · Journal of Neuroinflammation
58. Neuroimaging genetic risk for Alzheimer’s disease in preclinical individuals: from candidate genes to polygenic approaches
    Harrison, Theresa M., Bookheimer, Susan Y. · 2016 · Biological Psychiatry Cognitive Neuroscience and Neuroimaging
59. Do Alzheimer's Disease Risk Gene Products Actually Act in Microglia?
    Hashioka, Sadayuki, Inoue, Ken, Takeshita, Haruo, Inagaki, Masatoshi · 2020 · Frontiers in Aging Neuroscience